Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Wockhardt

Wockhardt
PUBLIC STATUS
5K-10K EMPLOYEES
532300 STOCK SYMBOL
4 INVESTMENTS
$4.02 SHARE PRICE (As of Monday Closing)
Description

Wockhardt Ltd is a major drug manufacturing company with a focus on pharmaceutical and biotechnology products. The company conducts research in the fields of pharmaceuticals and biotechnology while also operating its chain of Super Specialty Hospitals. The vast majority of the company's revenue is generated in India, followed by the USA and Europe. The company also operates in China, Japan, and Russia. The company's strategy includes the use of acquisitions, strategic partnerships, and contract manufacturing.

Formerly Known As
Worli Chemical Works
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
BOM
Primary Office
  • Wockhardt Towers
  • Bandra Kurla Complex, Bandra (East)
  • Mumbai, 400051
  • India

+91 022 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Wockhardt’s full profile, request a free trial.

Wockhardt Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$3.19 - $7.97 $445M $4.00 -$0.27 118K 111M

Wockhardt Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 402,633 705,207 1,235,421 1,226,914
Revenue 519,070 591,483 606,119 598,508
EBITDA 16,726 15,469 (42,434) 8,478
Net Income (30,073) (27,793) (94,352) (29,178)
Total Assets 1,103,863 1,127,600 1,253,689 1,391,143
Total Debt 367,903 485,909 575,665 641,289
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Wockhardt Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Wockhardt‘s full profile, request access.

Request full access to PitchBook

Wockhardt Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Glenmark Pharmaceuticals Corporation Mumbai, India 00000 00000 000000000 00000
000000000 000000 Corporation Hyderabad, India 00000
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
000000 00000 Corporation Mumbai, India 0000
00. 00000'0 000000 Corporation Hyderabad, India 00000 00000 000000 - 000 00000
To view this company’s complete list of competitors, request access »

Wockhardt Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 00000 10-Nov-2007 000000000000000000 00000 Pharmaceuticals 00000 00000000000
000000 00000 00000 23-Oct-2007 000000000000000000 0000 Drug Delivery
00000000 000000000 03-Oct-2007 000000000000000000 00000 Pharmaceuticals 00000 00000000000
Esparma 06-May-2004 Merger/Acquisition 0000 Pharmaceuticals
To view this company’s complete investment and acquisition history, request access »

Wockhardt Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 06-May-2004 000000000000000000 0000 Completed
  • 000000000
To view this company’s complete exits history, request access »

Wockhardt Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000000 Pharmaceuticals Clonmel, Ireland 0000
To view this company’s complete subsidiary history, request access »

Wockhardt Executive Team (7)

Name Title Board
Seat
Contact
Info
Manas Datta Chief Financial Officer
Ankeet Doshi Senior General Manager, Corporate Strategy and Business Development
Murtaza Khorakiwala Managing Director
Habil Khorakiwala Founder Chairman & Group Chief Executive Officer

3 Former Executives

You’re viewing 4 of 7 executives. Get the full list »

Wockhardt Board Members (1)

Name Representing Role Since Contact
Info
00000 00000000000 Wockhardt Founder Chairman & Group Chief Executive Officer 000 0000